Cited by 27Epilepsy research and treatmentNeuroscience and Neuropharmacology ResearchPharmacological Effects and Toxicity Studies

Antiseizure effects of TrkB kinase inhibition

Open access
Liu, Gumei, Kotloski, Robert J, McNamara, James O.·2014·Epilepsia

Abstract

Summary: Objective: The principal molecular targets of conventional antiseizure drugs consist of ligand‐gated and voltage‐gated ion channels and proteins subserving synaptic function. Inhibition of the receptor tyrosine kinase TrkB limits epileptogenesis, but its effect on individual seizures is unknown. We sought to determine whether inhibition of TrkB kinase exerts an antiseizure effect. Methods: We utilized the kindling model in combination with an inducible conditional knockout of the TrkB gene (Act‐Cre ER TrkBflox/flox mice treated with tamoxifen), and also with a chemical‐genetic approach in which mice carry a TrkB kinase with a phenylalanine to alanine substitution of residue 616 (TrkBF616A), which allows inhibition of the kinase by a blood–brain barrier permeable small molecule, 1′‐naphthylmethyl‐4‐amino‐1‐tert‐butyl‐3‐(p‐methylphenyl)pyrazolo[3,4‐d]pyrimidine (1 NMPP 1). Results: Following induction of kindling, reduction of TrkB protein levels in Act‐Cre ER TrkBflox/flox mice treated with tamoxifen was associated with reduced severity of behavioral seizures evoked by stimulation. Treatment with 1 NMPP 1 for 2 weeks following induction of kindling reversibly elevated both focal electrographic and generalized seizure thresholds in TrkBF616A, but not wild‐type (WT), mice. In contrast to kindled animals, treatment of naive TrkBF616A mice for 2 weeks had no detectable effect on electrographic seizure threshold (EST). Significance: This study provides proof of concept of a novel molecular target for antiseizure drugs, namely the receptor tyrosine kinase TrkB. A PowerPoint slide summarizing this article is available for download in the Supporting Information section here.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/epi.12671

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Transient inhibition of the BDNF receptor TrkB after seizure induction prevents the development of temporal lobe epilepsy.

    “Other studies have shown that transient inhibition of the BDNF receptor TrkB after seizure induction prevents the development of temporal lobe epilepsy [186, 187].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [1]Ropper AH Samuels MA Adams RD Adams and Victor's principles of neurology McGraw-Hill's AccessMedicine Clinical library 2009 9th ed. New York McGraw-Hill 1 electronic text (1572 p.).

Cited by

Sorted by citations

Authors
Liu, G., Kotloski, R. J., & McNamara, J. O.
Affiliations
Duke Medical Center (US)
Corresponding author
McNamara, James O.
Venue
Epilepsia
Publisher
Wiley
Published
2014-06-05
Volume
55
Issue
8
Pages
1264-1273
ISSN
  • 0013-9580 (ISSN-L)
  • 1528-1167
OpenAlex
W1996433749
Cited by
27
References
19
Citations by year
2026: 1 · 2025: 2 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 3 · 2020: 1 · 2019: 1 · 2018: 5 · 2017: 3 · 2016: 5 · 2015: 1 · 2014: 1
FWCI
2.54
Type
journal article
Language
en
Open access
Locations
  • Epilepsia (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Neurological Disorders and Stroke (NS056217)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Epilepsy research and treatment
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
Keywords
antiepileptic drugs, kindling, receptor tyrosine kinase, conditional knockout mice, epilepsy, kinase inhibitors
MeSH terms
Animals, Anticonvulsants, Membrane Glycoproteins, Mice, Inbred C57BL, Mice, Transgenic, Protein Kinases, Protein-Tyrosine Kinases, Seizures, Treatment Outcome, Receptor, trkB, Protein Kinase Inhibitors, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review